Trial
NCT02589366
Lymphoseek as Lymphoid Tissue Targeting Agent in Patients With Cancer of the Endometrium
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of California, San Diego
Collaborators
Cardinal Health 414, LLC
Condition
Endometrial Cancer
Intervention
Lymphoseek plus Vital Blue Dye
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-10-15